Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral: Vanier Canada Graduate Scholarships

University of Toronto

$150,000.00

A comprehensive analysis of epigenetic mediated silencing governing medulloblastoma metastasis and the identification of neuronal differentiation genes as targets of DNA hypermethylation.

FY 2009-10

Summary
Medulloblastoma, is a paediatric brain tumour that affects the lives of 300 Canadian children annually - most under the age of 15. Treatment involves surgery in conjunction with radio- and chemotherapy regiments resulting in a 70% 5-year survival rate, however this aggressive treatment often leaves survivors with a severely decreased quality of life due to physical and cognitive limitations. Currently, and of grievous importance, there exists no way to predict medulloblastoma formation and in the majority of cases their cause is not clearly understood. Recent advances in genetic technology have afforded us with a greater understanding of this disease. Specifically, we can now divide medulloblastoma into four separate subtypes, each with their own prognostic factors and survival outcomes. However, the most aggressive forms of medulloblastoma are still poorly understood. These tumours represent nearly 50% of all diagnosed cases and are typically metastatic. We aim to understand novel changes that propagate these aggressive tumours by investigating over 400 metastatic medulloblastomas using the highest resolution technology available. Through extensive genetic and epigenetic analyses, animal models recapitulating the tumour and international collaborations with St. Jude's Children's Hospital and the German Cancer Research Centre, we aim to identify candidates for targeted therapy of metastatic medulloblastoma in the hopes of improving quality of life for survivors.
Program
Doctoral: Vanier Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
197420
Name
Dubuc Adrian M
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Clinical
Prcname2
Vanier Canada Graduate Scholarships CIHR
Projecttitle
A comprehensive analysis of epigenetic mediated silencing governing medulloblastoma metastasis and the identification of neuronal differentiation genes as targets of DNA hypermethylation.
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
Doctoral: Vanier Canada Graduate Scholarships
Keyworddelim
Chromatin; Dna Methylation; Epigenetics; Medulloblastoma; Metastasis; Neuronal Differentiation
Abstract
Medulloblastoma, is a paediatric brain tumour that affects the lives of 300 Canadian children annually - most under the age of 15. Treatment involves surgery in conjunction with radio- and chemotherapy regiments resulting in a 70% 5-year survival rate, however this aggressive treatment often leaves survivors with a severely decreased quality of life due to physical and cognitive limitations. Currently, and of grievous importance, there exists no way to predict medulloblastoma formation and in the majority of cases their cause is not clearly understood. Recent advances in genetic technology have afforded us with a greater understanding of this disease. Specifically, we can now divide medulloblastoma into four separate subtypes, each with their own prognostic factors and survival outcomes. However, the most aggressive forms of medulloblastoma are still poorly understood. These tumours represent nearly 50% of all diagnosed cases and are typically metastatic. We aim to understand novel changes that propagate these aggressive tumours by investigating over 400 metastatic medulloblastomas using the highest resolution technology available. Through extensive genetic and epigenetic analyses, animal models recapitulating the tumour and international collaborations with St. Jude's Children's Hospital and the German Cancer Research Centre, we aim to identify candidates for targeted therapy of metastatic medulloblastoma in the hopes of improving quality of life for survivors.
Competitiondate
200911
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Dubuc, Adrian M
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~
University of Toronto - $150,000 Grant (2009-10) | Canada Spends